Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuang Lu

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Biopharmaceutics & Drug Disposition|November 29, 2019
In vitro and in vivo methods to assess pharmacokinetic drug- drug interactions in drug discovery and developmentChuang Lu, Li Di
Acta Pharmaceutica Sinica. B|December 3, 2016
PBPK modeling and simulation in drug research and developmentXiaomei Zhuang, Chuang Lu
Sensors (Basel, Switzerland)|April 13, 2024
Adaptive Control for Virtual Synchronous Generator Parameters Based on Soft Actor CriticChuang Lu, Xiangtao Zhuan
Current Drug Metabolism|June 21, 2020
2020 FDA Drug-drug Interaction Guidance: A Comparison Analysis and Action Plan by Pharmaceutical Industrial ScientistsSirimas Sudsakorn, Praveen Bahadduri, Jennifer Fretland, et al.
Biopharmaceutics & Drug Disposition|September 30, 2014
Assessment of cytochrome P450-mediated drug-drug interaction potential of orteronel and exposure changes in patients with renal impairment using physiologically based pharmacokinetic modeling and simulationChuang Lu, Ajit Suri, Wen Chyi Shyu, et al.
Current Drug Discovery Technologies|September 17, 2010
Emerging in vitro tools to evaluate cytochrome P450 and transporter-mediated drug-drug interactionsChuang Lu, Mingxiang Liao, Lawrence Cohen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 17, 2005
Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomibVinita Uttamsingh, Chuang Lu, Gerald Miwa, et al.
Optics Express|November 6, 2019
Time-resolved continuous-filtering Vernier spectroscopy of H<sub>2</sub>O and OH radical in a flameChuang Lu, Francisco Senna Vieira, Florian M Schmidt, et al.
Heliyon|September 7, 2023
Research on microseismic localization algorithm with global search and local optimizationYimin Song, Yazhou Zhao, Yuanyu Zhang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 12, 2011
A refined cytochrome P540 IC₅₀ shift assay for reliably identifying CYP3A time-dependent inhibitorsPing Li, Chuang Lu, Suresh K Balani, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Biopharmaceutics & Drug Disposition|November 29, 2019
In vitro and in vivo methods to assess pharmacokinetic drug- drug interactions in drug discovery and developmentChuang Lu, Li Di
Acta Pharmaceutica Sinica. B|December 3, 2016
PBPK modeling and simulation in drug research and developmentXiaomei Zhuang, Chuang Lu
Sensors (Basel, Switzerland)|April 13, 2024
Adaptive Control for Virtual Synchronous Generator Parameters Based on Soft Actor CriticChuang Lu, Xiangtao Zhuan
Current Drug Metabolism|June 21, 2020
2020 FDA Drug-drug Interaction Guidance: A Comparison Analysis and Action Plan by Pharmaceutical Industrial ScientistsSirimas Sudsakorn, Praveen Bahadduri, Jennifer Fretland, et al.
Biopharmaceutics & Drug Disposition|September 30, 2014
Assessment of cytochrome P450-mediated drug-drug interaction potential of orteronel and exposure changes in patients with renal impairment using physiologically based pharmacokinetic modeling and simulationChuang Lu, Ajit Suri, Wen Chyi Shyu, et al.
Current Drug Discovery Technologies|September 17, 2010
Emerging in vitro tools to evaluate cytochrome P450 and transporter-mediated drug-drug interactionsChuang Lu, Mingxiang Liao, Lawrence Cohen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 17, 2005
Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomibVinita Uttamsingh, Chuang Lu, Gerald Miwa, et al.
Optics Express|November 6, 2019
Time-resolved continuous-filtering Vernier spectroscopy of H<sub>2</sub>O and OH radical in a flameChuang Lu, Francisco Senna Vieira, Florian M Schmidt, et al.
Heliyon|September 7, 2023
Research on microseismic localization algorithm with global search and local optimizationYimin Song, Yazhou Zhao, Yuanyu Zhang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 12, 2011
A refined cytochrome P540 IC₅₀ shift assay for reliably identifying CYP3A time-dependent inhibitorsPing Li, Chuang Lu, Suresh K Balani, et al.
Pageof 8